Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

Item

http://www.wikidata.org/entity/Q28236359

Q28236359

about

Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract Chromogranin A: its clinical value as marker of neuroendocrine tumours Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms.Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis.A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism Consensus on biomarkers for neuroendocrine tumour disease Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms.Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells.A systematic review of diagnostic procedures to detect midgut neuroendocrine tumors.The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.Endoscopic resection for gastrointestinal neuroendocrine tumors.Chromogranin A as a biomarker in cardiovascular disease.Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .Biochemical diagnosis of neuroendocrine GEP tumor.Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans.Serum pancreastatin: the next predictive neuroendocrine tumor marker.Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression.

P2860

Q28242045-CD6AFEEA-283F-456B-B0FE-A32A55CA742C Q28278648-02FF8DEE-6946-4683-B4DE-FAC41D6BF297 Q30395656-B9FDA0AD-96C1-4F6B-BE25-ED7CD4297665 Q30486618-F9B9990A-B707-45F8-A7C1-618FF2E526C1 Q31955600-CD88B42A-ECC3-46D1-AEA0-B62C2CCD815B Q33653647-F6FE31FD-9390-4310-A57A-CDD82A1FB74D Q33909582-919D2C0A-DB51-4D33-A173-9F3E28C62BA6 Q34157385-38F8AD5A-223F-4686-9244-5602B04EE8F3 Q34573558-C35977C4-DBEC-4EB3-972B-9D51C5288F1C Q34730350-20953F5B-1F6E-4DF5-8E84-243DA76F6A72 Q34810946-504A255A-E1FF-4144-8083-67A75AA4BB20 Q35010543-C7DF632C-A59F-44A6-A482-708C7A754ECB Q35093730-6699C015-E46B-4FA9-A590-5AB4042F3222 Q35351719-5298C860-555F-4B4D-A684-7415B833F875 Q35486383-85A870C3-1EBA-4DD4-A633-9C3162BC26C6 Q35493206-BF0D9D1A-4A3A-4C58-B206-C05F2E6F858C Q36617255-1A59AB3A-6FE1-4998-AC7F-F65023C4DBF3 Q36665034-548C3EF3-0C95-4D92-838F-4A88D1EBD491 Q36972684-A466D8A8-003C-4BD5-9E97-615B2E686A1A Q37255681-7218EB75-7488-44AE-A3B9-D89261777D3E Q37259309-5B99EA1D-AFA2-438F-8996-843B173B38E6 Q37615044-6C55618E-F162-431B-89EB-272E1E26E589 Q37647361-057E7BD1-A7AF-4F6D-9111-FAF0420ED508 Q37784764-1476D46B-E0CF-419A-BD7A-20E1E9522372 Q37869391-B978F31C-D5F8-4F16-8667-7D9FF1375ECE Q38132280-90C9437C-A6F0-45A6-B9DD-47ADEE9B2BA1 Q38170143-D0803DBF-7605-4D19-8793-9F82A63ED561 Q38648214-DD6317F6-118A-4449-8C88-994860013BFA Q39665909-108C366D-F3AC-4478-BBA8-9386CDC96BD4 Q40905638-C255FDFA-2D5E-4B7D-A491-262F55E7359C Q41566908-7D7EDB9D-B23D-422E-9E0E-3E388967F727 Q42436389-8A4BD2F1-0418-4ED2-B6F2-0EB1E2FFF449 Q42458822-8F53A8C3-ABD5-4BC3-8ED7-4AAD4BDAFA34 Q42523235-A6905DC3-3CA0-4FA1-BBBB-4B9DA550D129 Q42810043-8C01B2DF-BD41-48CD-8698-CF8D1ACD34D0 Q44892490-F411C7C4-AAEE-4F72-A2CA-38FAC9E48DBF Q44969569-E464C243-49D9-4EE4-B868-56E94A432860 Q45327633-E0D55B22-DFF6-4CBA-A585-DAFDDA72DB8B Q46012825-9C45B8BD-7DEA-4740-9CFB-DF978AA11D03 Q49959833-E84D9143-AEC4-4F0A-B411-8EAD0E7FD9BD

P2860

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

Item

http://www.wikidata.org/entity/Q28236359

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu